Skip to main content
NBIX logo

NBIX

Neurocrine Biosciences, Inc.

$176.00

2.52%

Trade Ideas Performance

Latest Closed Trade Idea

$176.00

2.52%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

4

Social

31

About

Events of Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences' stock has experienced several notable events in the past six months. The company reported strong Q1 2026 financial results with net product sales exceeding $800 million, driven by INGREZZA and CRENESITY. Neurocrine Biosciences announced an agreement to acquire Soleno Therapeutics, including VYKAT XR. Several investment banks have updated their ratings and price targets for NBIX. As of May 8, 2026, NBIX stock was priced at $149.59, increasing by 7.3% since January 1st, 2026, and by 27.25% over the last 12 months.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Neurocrine Biosciences, Inc. (NBIX) Live Stock Price, Chart & Financial News | Edge Hound